Third Harmonic Bio Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +166.3% | -2.0% | -2.4% | -1.9% | -1.2% | -1.6% | -2.6% | -1.7% | +14.5% | -3.2% | -5.0% | |
| – | +167.8% | -3.5% | -2.4% | -1.9% | -1.3% | -1.5% | -2.5% | -1.6% | +14.9% | -3.2% | -5.0% | |
| – | +165.7% | -3.6% | -2.3% | -1.4% | -1.5% | -1.8% | -2.3% | -2.9% | +16.0% | -3.7% | -4.7% | |
| – | +165.7% | -3.6% | -2.3% | -1.4% | -1.5% | -1.8% | -2.3% | -2.9% | +16.0% | -3.7% | -4.7% | |
| – | – | – | -98.6% | +7,050.0% | – | – | – | – | – | – | – | |
| – | -96.4% | +51.5% | -9.2% | -10.4% | +18.9% | -7.2% | -18.6% | +30.2% | +5.4% | -1.9% | -23.7% | |
| – | +32.0% | -10.8% | -12.5% | -14.6% | +39.4% | -8.0% | -25.8% | +58.1% | +11.2% | +0.6% | -28.2% | |
| – | – | – | -13.2% | +107.5% | +3.8% | +3.6% | +3.8% | -48.2% | +3.5% | +3.6% | +3.5% | |
| – | +37.0% | -37.5% | +27.9% | -49.7% | +46.8% | -6.7% | -48.6% | +52.3% | +98.5% | -32.2% | +38.5% | |
| – | – | -3.1% | -2.2% | -1.6% | -1.8% | -1.4% | -2.1% | -2.6% | +14.9% | -3.3% | -4.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -76.4% | +331.8% | +0.2% | +0.3% | +0.3% | +0.6% | +0.7% | +0.9% | +1.9% | +0.0% | +8.7% |
Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.